Binding fusion proteins, binding fusion protein-drug conjugates, XTEN-drug conjugates and methods of making and using same

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9249211
SERIAL NO

13631361

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to binding fusion protein compositions comprising targeting moieties linked to extended recombinant polypeptide (XTEN), binding fusion protein-drug conjugate compositions, and XTEN-drug conjugate compositions, isolated nucleic acids encoding the compositions and vectors and host cells containing the same, and methods of using such compositions in treatment of diseases, disorders, and conditions.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
AMUNIX PHARMACEUTICALS INC2 TOWER PLACE #1100 SOUTH SAN FRANCISCO CA 94080-1826

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Geething, Nathan San Juan, US 29 839
Schellenberger, Volker Palo Alto, US 137 3339
Silverman, Joshua Sunnyvale, US 61 1372
Spink, Benjamin San Carlos, US 39 893
Stemmer, Willem P Los Gatos, US 45 1755
Wang, Chia-wei Milpitas, US 156 2513

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Aug 2, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00